Wellness Genomics Market Report 2026

The wellness genomics market size has grown rapidly in recent years. It will grow from $5.67 billion in 2025 to $6.44 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to growing consumer awareness of genetic health insights, declining costs of genetic testing, expansion of online wellness platforms, increased focus on preventive healthcare, rising adoption of personalized health programs.

The wellness genomics market size is expected to see rapid growth in the next few years. It will grow to $10.61 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing integration of genomics with digital health apps, growing demand for predictive wellness analytics, expansion of ai-driven lifestyle recommendations, rising focus on long-term health optimization, increased acceptance of genomics in daily wellness decisions. Major trends in the forecast period include increasing adoption of direct-to-consumer genomic testing, rising integration of lifestyle and genetic data platforms, growing demand for personalized nutrition and fitness insights, expansion of preventive health genomics applications, enhanced focus on data privacy and genetic security.

The growing demand for personalized medicine is expected to drive the growth of the wellness genomics market in the coming years. Personalized medicine is an approach to healthcare that tailors treatment and care to an individual’s unique genetic makeup, lifestyle, and health conditions, enabling more precise and effective outcomes. Demand for personalized medicine is increasing as advances in genetic technology make it easier to customize treatments based on an individual’s genetic profile, resulting in more targeted and effective therapies. Wellness genomics supports personalized medicine by providing genetic insights that guide lifestyle and preventive health strategies specific to each person’s biological makeup. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, more than doubling the six approvals granted in 2022. Therefore, the rising demand for personalized medicine is fueling growth in the wellness genomics market.

Key companies in the wellness genomics market are focusing on developing innovative solutions, such as personalized genomics platforms, to provide tailored health insights and lifestyle recommendations based on an individual’s genetic profile. A personalized genomics platform is a technology or service that analyzes a person’s genetic data to deliver customized health insights and recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service provider, launched Geniee, a personalized genomics platform that provides individuals with health insights based on their genetic makeup. Geniee offers comprehensive genetic testing to help users understand how their genes influence responses to medications, diet, exercise, and nutrition. By leveraging this information, users can optimize their health through personalized wellness plans, early risk detection, and improved treatment strategies. The platform empowers individuals to take proactive control of their health, representing a significant advancement in personalized medicine and preventive healthcare.

In September 2023, InformedDNA, a US-based precision health company, acquired gWell Health for an undisclosed amount. Through this acquisition, InformedDNA aims to integrate gWell’s personalized wellness technology with its clinical genetics expertise, expanding precision healthcare into areas such as oncology, drug metabolism, and maternity care, while increasing access to genomic-guided decision-making. gWell Health is a US-based digital health and wellness company that leverages genomics to create personalized wellness plans.

Major companies operating in the wellness genomics market are 23andMe Holding Co., Color Health Inc., Variantyx Inc., Segterra Inc., Dante Labs Inc., Pathway Genomics Corporation, Futura Genetics Ltd., Genopalate Inc., OhMyGene Inc., Rootine Labs Inc., Toolbox Genomics Inc., Xcode Life Sciences Pvt Ltd., GenepoweRx Healthcare Pvt Ltd., Gx Sciences Inc., Nebula Genomics Inc., AncestryDNA, MyHeritage, Living DNA, Helix, Vitagene, DNAfit, CircleDNA, NutriGenomix.

North America was the largest region in the wellness genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wellness genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wellness genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the wellness genomics market by increasing costs of imported sequencing reagents, laboratory consumables, testing kits, and bioinformatics hardware used in consumer genomics and predictive testing services. North America and Europe are most affected due to reliance on imported sequencing technologies, while Asia-Pacific faces higher costs for test kit manufacturing and distribution. These tariffs are raising service pricing and limiting affordability for mass-market consumers. However, they are also encouraging localized kit manufacturing, regional laboratory expansion, and development of cost-optimized genomic testing solutions.

The wellness genomics market research report is one of a series of new reports that provides wellness genomics market statistics, including wellness genomics industry global market size, regional shares, competitors with a wellness genomics market share, detailed wellness genomics market segments, market trends and opportunities, and any further data you may need to thrive in the wellness genomics industry. This wellness genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Wellness genomics refers to the use of an individual’s genetic information to provide personalized recommendations for enhancing health, nutrition, fitness, and overall well-being. Its goal is to optimize lifestyle choices and prevent disease by analyzing genetic predispositions beyond the scope of traditional medical genetics.

The primary types of wellness genomics include predictive testing, consumer genomics, and others. Predictive testing is a form of genetic testing used to determine whether an asymptomatic individual carries a gene variant that could lead to disease in the future. It is conducted in various settings, including direct-to-consumer (DTC) and professional environments, and has applications such as breast and ovarian cancer screening, diabetes screening and monitoring, colon cancer screening, Alzheimer’s disease risk assessment, prostate cancer screening, orthopedic and musculoskeletal evaluation, and more.

The wellness genomics market consists of revenues earned by entities providing services such as genetic testing, personalized nutrition analysis, fitness and wellness recommendations, disease risk assessment, ancestry and trait analysis, and preventive healthcare insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The wellness genomics market also includes sales of genetic testing kits, bioinformatics software, personalized health reports, and nutrigenomics supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.